James Bennett
Insider
First SEC filing: Sept. 22, 2004 · Latest: Sept. 22, 2004
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 19, 2010 | BIO | S | 2,237 | $95.00 | $212,515 | 34,329 Direct | -6.12% | Disposed | 288.6% (price as of 2026-10-02) |
| Nov. 19, 2010 | BIO | S | 1,783 | $95.15 | $169,652 | 32,546 Direct | -5.19% | Disposed | 288.0% (price as of 2026-10-02) |
| Feb. 8, 2007 | BIO | M | 3,000 | $28.61 | $85,830 | 36,566 Direct | +8.94% | Acquired | 1190.2% (price as of 2026-10-02) |
| Feb. 8, 2007 | BIO | M | 3,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2006 | BIO | M | 3,000 | $28.61 | $85,830 | 33,566 Direct | +9.81% | Acquired | 1190.2% (price as of 2026-10-02) |
| March 31, 2006 | BIO | M | 3,000 | · | · | 3,000 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Nov. 7, 2005 | BIO | S | 20,000 | $59.78 | $1,195,600 | 30,566 Direct | -39.55% | Disposed | 517.5% (price as of 2026-10-02) |
| Aug. 9, 2005 | BIO | S | 10,000 | $55.76 | $557,600 | 50,566 Direct | -16.51% | Disposed | 562.0% (price as of 2026-10-02) |
| July 14, 2005 | BIO | M | 3,000 | $28.61 | $85,830 | 60,566 Direct | +5.21% | Acquired | 1190.2% (price as of 2026-10-02) |
| July 14, 2005 | BIO | M | 3,000 | · | · | 6,000 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 6,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 3,472 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 1,908 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 3,624 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 1,528 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 5,592 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 6,000 | $28.61 | $171,660 | 57,566 Direct | +11.64% | Acquired | 1190.2% (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 3,472 | $10.75 | $37,324 | 51,566 Direct | +7.22% | Acquired | 3333.9% (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 1,908 | $10.75 | $20,511 | 48,094 Direct | +4.13% | Acquired | 3333.9% (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 1,528 | $10.75 | $16,426 | 46,186 Direct | +3.42% | Acquired | 3333.9% (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 5,592 | $10.75 | $60,114 | 44,658 Direct | +14.31% | Acquired | 3333.9% (price as of 2026-10-02) |
| Sept. 20, 2004 | BIO | M | 3,624 | $11.94 | $43,271 | 39,066 Direct | +10.23% | Acquired | 2991.6% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 8, 2007 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $28.61 | Feb. 6, 2012 | 3,000 | Disposed |
| March 31, 2006 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $28.61 | Feb. 6, 2012 | 3,000 | Disposed |
| July 14, 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $28.61 | Feb. 6, 2012 | 3,000 | Disposed |
| Sept. 20, 2004 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $28.61 | Feb. 6, 2012 | 6,000 | Disposed |
| Sept. 20, 2004 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $10.75 | Sept. 19, 2010 | 3,472 | Disposed |
| Sept. 20, 2004 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $10.75 | Sept. 19, 2010 | 1,908 | Disposed |
| Sept. 20, 2004 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $11.94 | Feb. 2, 2010 | 3,624 | Disposed |
| Sept. 20, 2004 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $10.75 | Sept. 19, 2010 | 1,528 | Disposed |
| Sept. 20, 2004 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock | $10.75 | Sept. 19, 2010 | 5,592 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2002 | $494,000 | $311,220 | · | · | · | · | $10,000 | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.